New population-based analyses measure incidence and prevalence of lupus among these fast growing U.S. populations.
Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.
Patient-reported data collected in the Registry will accelerate the development of new treatments and help to unravel the mysteries of lupus.
Latest LFA Collective Data Analysis Initiative (CDAI) study yields important results and was recently published in the premier rheumatology journal, Arthritis and Rheumatology.
This data comes as welcome news for patients with lupus-related kidney disease.
The Foundation is currently accepting applications from lupus investigators and student researchers for our Career Development and Student Summer Fellowship grant programs.
In a victory for research advocates, on December 13, President Barack Obama signed the 21st Century Cures Act into law.
Fast Track is a process designed to expedite FDA review and get important new drugs to the patient earlier.